Jury Awards Guardant Health $292.5 Million in False Advertising Case Against Rival Natera
San Francisco, CA – A federal jury in California delivered a significant verdict favoring Guardant Health in a legal battle against Natera Inc., awarding the medical test manufacturer a substantial $292.5 million in damages. The jury found that Natera had engaged in false advertising regarding its colorectal cancer test, which it claimed was superior to Guardant Health’s Reveal test. The decision arrived after a contentious legal confrontation, underscoring the fierce competition within the biotechnology sector, particularly in the development and marketing of cancer diagnostic tests. This lawsuit highlights the critical role of accurate and truthful … Read more